HLPVSPACB• 3 Months (Normalized)
HLP vs PACB (Hongli Group Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Jul 8 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HLP Performance $2.52
+169.52%
Hongli Group Inc.
Normalized Baseline0.00%
PACB Performance $2.7
+80%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin HLP LEADS
+89.52 pts
HLP outperforming by 89.52 percentage points
HLPPACB
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HLP PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | HLP Price | HLP Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $2.52 | +169.52% | $2.70 | +80.00% | +89.52% |
| Oct 05, 2026 | $2.47 | +164.17% | $2.87 | +91.33% | +72.84% |
| Oct 02, 2026 | $2.55 | +172.73% | $2.54 | +69.33% | +103.40% |
| Oct 01, 2026 | $- | $2.51 | +67.33% | - | |
| Sep 30, 2026 | $- | $2.37 | +58.00% | - | |
| Sep 29, 2026 | $- | $1.83 | +22.00% | - | |
| Sep 28, 2026 | $2.39 | +155.61% | $1.71 | +14.00% | +141.61% |
| Sep 25, 2026 | $2.21 | +136.36% | $- | - | |
| Sep 24, 2026 | $2.20 | +135.29% | $1.46 | -3.00% | +138.29% |
| Sep 23, 2026 | $2.04 | +117.65% | $1.41 | -6.00% | +123.65% |
| Sep 22, 2026 | $2.00 | +113.90% | $- | - | |
| Sep 21, 2026 | $2.03 | +117.11% | $1.36 | -9.33% | +126.44% |
| Sep 18, 2026 | $2.02 | +116.04% | $1.37 | -8.67% | +124.71% |
| Sep 17, 2026 | $2.02 | +116.04% | $1.38 | -8.00% | +124.04% |
| Sep 16, 2026 | $2.07 | +121.39% | $1.34 | -10.67% | +132.06% |
Page 1 of 5